Novartis Pharms. Corp. v. Watson Labs., Inc.

Novartis Pharms. Corp. v. Watson Labs., Inc.

The cases were tried separately, but both focused on a common limitation in all claims requiring the presence of an “antioxidant” in the composition. The court construed the term “antioxidant” as “an agent of that reduces oxidative degradation.” Watson

(Visited 3 times, 1 visits today)
4
Like
Save

Comments

Comments are disabled for this post.